Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06013956 · ClinicalTrials.gov registry record · Phase 4

Personalized Real-Time DBS and PD Mechanisms

A Phase 4 study of Parkinson Disease, sponsored by David Escobar.

Recruiting
Registry status
Phase 4
Development phase
25
Enrollment target
1
Study location

NCT06013956 is a Phase 4 study of Parkinson Disease that is actively recruiting participants, run by David Escobar. The registered enrollment target is 25 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06013956, a Phase 4 study of Parkinson Disease, is actively recruiting participants, sponsored by David Escobar.

RECRUITING
Registry status
Phase 4
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

A prospective cohort of patients scheduled to undergo deep brain stimulation (DBS) implantation surgery for the treatment of Parkinson's disease as per standard of care will be invited to participate in this study. This mechanistic study is aimed at better understanding the role of basal ganglia beta band (11-35 Hz) oscillations and resonance in the manifestation of Parkinson's disease (PD) motor signs using closed-loop electrical neurostimulation, levodopa medication, and computational modeling. The ultimate goal of this study is to inform the development of closed-loop neuromodulation technology that can be programmed and adjusted in real time based on patient-specific neural activity.

Conditions Studied

Interventions

  • DEVICE Neurostimulation
  • DRUG Carbidopa 25/Levodopa 100Mg Tab

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-08-29
Est. Completion 2028-06-30
Phase Phase 4

Sponsor

David Escobar

1 total trials

What the Registry Record Tells You About NCT06013956

The ClinicalTrials.gov registry entry for NCT06013956 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is David Escobar, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Neurostimulation is the first listed.

NCT06013956 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06013956 about?

NCT06013956 is a clinical study titled "Personalized Real-Time DBS and PD Mechanisms". A prospective cohort of patients scheduled to undergo deep brain stimulation (DBS) implantation surgery for the treatment of Parkinson's disease as per standard of care will be invited to participate in this study. This mechanistic study is aimed at better understanding the role of basal ganglia bet...

What is the current status of trial NCT06013956?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2023-08-29. Estimated completion is 2028-06-30.

What conditions does trial NCT06013956 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06013956?

The interventions under investigation include: Neurostimulation (DEVICE), Carbidopa 25/Levodopa 100Mg Tab (DRUG).

Who is sponsoring clinical trial NCT06013956?

This trial is sponsored by David Escobar, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06013956 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.